Maybe you’ve been thinking of registering for this year’s Cannabis Capital Summit and wanted some reasons to say “yes”. Well, here’s what you’ve been waiting for!
Author Archive for: Peter
This author has yet to write their bio.Meanwhile lets just say that we are proud Peter contributed a whooping 53 entries.
Entries by Peter
Arguably the team is the most important factor in angel capital and venture capital investing, but the proper way to create a team slide seems to remain a mystery to many. For example, if you are one of those companies that puts the team slide up in the front of your deck, I have to […]
You may be asking yourself whether we’re in a tech bubble. Check out these valuation multiples from CB Insights on some of the top “unicorn” companies and decide for yourself.
RVC’s Inside Venture Capital! Tuesday 4/14/15, 5:00–7:30 Denver Metro Chamber of Commerce 1445 Market St. Denver, CO. 80202. 5th Floor Inside Venture Capital
If I could have any job in the world, it would be to be a full time angel investor. Angels get to meet super-smart people with cutting edge ideas, they work with other angels who have deep sector expertise and ask great questions, they are intellectually stimulated in evaluating and negotiating deals and they can […]
Watch the video
Where are all the Angel Investors? I get asked this question all the time and the answer is simple – “They’re all around you.” But identifying them and building a collective network of angels to pool funds together to invest in deals is not easy in Colorado. We’re lacking in Google and Facebook millionaires, and […]
Here’s a great InfoGraphic from CBInsights with the healthcare venture capital landscape marked out by type. This is how to find the funding source for life science, healthcare and device startups.
Venture capital funding hit its highest annual mark since 2001 as venture investors participated in $47.3 billion across 3,617 deals. Even versus 2013, the past year was huge as venture capital skyrocketed 62% YoY due to multiple $500M+ mega-rounds while deal growth was more modest, climbing 8%. Of note, two quarters each – Q2’14 and […]
Here’s a great article from CB Insights